Conventional immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, can reinvigorate T cells but ...
Machine-learning analysis identifies factors predicting T cell collection efficiency in CAR T-cell therapy for DLBCL patients. Higher blood volume, not higher circulating T-cell numbers, correlates ...
T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on exquisitely timed molecular signals. Now researchers have captured one of the ...
FDA fast track designation enables increased regulatory interaction and potential rolling BLA review for RPTR-1.201 in ...
Cytospire Therapeutics has secured $83 million in Series A funding to progress its first-in-class pan-gamma delta T cell engagers into clinical trials for cancer. The approach aims to overcome safety ...
London, UK-based Cytospire said this morning that it has raked in £61 million ($83 million) in the round, which will fund its development of "pan-gamma delta" TCEs, targeting a subset of ...
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the immune system. St. Jude Children's Research Hospital scientists recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results